THE CARDIOVASCULAR DISTRESS TRIGGERED BY SARS-COV-2 MIGHT HELP TO SHAPE AN ULTIMATE FATAL IMMUNE INS

2021-01-10 2021-02-19 2021-02-21 9/30/2024 10:36:02 AM Journal of Applied Molecular Cell Biology 8 2021 Editorial 1 5 2021 24122580.8.1 http://dx.doi.org/10.21065/24122580.8.1 English Julio L. Padron Velazquez CARDIOVASCULAR DISTRESS, SARS-COV-2 , MULTI-DISCIPLINARY, THERAPEUTIC APPROACH. The corona virus SARS-CoV-2 is the etiologic agent of the current pandemic outbreak of COVID-19 that is afflicting humankind through the whole globe since December of 2019 [1]. Huge efforts and resources are focused on many aspects of COVID-19 pathology and therapy, and indeed important advancements have been obtained in a relative short period of time. Following modest success with several intuitive and empirical therapeutic approaches (antiviral, antibiotics, anticoagulant, cortisone, immunosuppressive, cytokines) [2] most hopes are currently paying attention to a number immune based therapeutics such as several vaccines already entered in large clinical use [3]